menu
    • menu

    Company profile for Anixa Biosciences

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Anixa is a biotechnology company developing a number of programs addressing cancer and infectious disease. Anixa's therapeutics portfolio includes a cancer vaccine technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC), a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a COVID-19 therape...
    Anixa is a biotechnology company developing a number of programs addressing cancer and infectious disease. Anixa's therapeutics portfolio includes a cancer vaccine technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC), a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a COVID-19 therapeutics program focused on inhibiting certain viral protein function.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Anixa BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3150 Almaden Expressway Suite 250 San Jose, CA 95118
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.anixa.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/anixabiosciences/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/anixabio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Products Expo

    Natural Products Expo

    Not Confirmed

    envelop Contact Supplier

    Natural Products Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anixa Bio To Keynote Sc Clinical & Translational Research
    Anixa Bio To Keynote Sc Clinical & Translational Research

    23 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/anixa-biosciences-announces-dr-jose-conejo-garcia-will-keynote-the-south-carolina-clinical--translational-research-institute-2026-retreat-302694019.html

    PR NEWSWIRE
    23 Feb 2026
    Share Share
    Anixa Bio Sees Positive Ovarian Cancer CAR-T Trial Results;
    Anixa Bio Sees Positive Ovarian Cancer CAR-T Trial Results;

    09 Feb 2026

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/anixa-biosciences-reports-encouraging-patient-survival-observations-in-ovarian-cancer-car-t-trial-achieves-regulatory-approval-enabling-major-dose-escalation-302681799.html

    PR NEWSWIRE BIO
    09 Feb 2026
    Share Share
    Anixa Biosciences Gets USAN Council Approval For CAR-T Therapy
    Anixa Biosciences Gets USAN Council Approval For CAR-T Therapy

    02 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/anixa-biosciences-secures-united-states-adopted-names-council-approval-of-non-proprietary-name-for-its-car-t-therapy-a-key-step-toward-future-commercialization-302675909.html

    PR NEWSWIRE
    02 Feb 2026
    Share Share
    Anixa Biosciences Granted Patent By (IMPI) For Breast Cancer
    Anixa Biosciences Granted Patent By (IMPI) For Breast Cancer

    27 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/anixa-biosciences-receives-notice-of-allowance-from-mexican-institute-of-industrial-property-impi-for-patent-covering-breast-cancer-vaccine-technology-302670617.html

    PR NEWSWIRE
    27 Jan 2026
    Share Share
    Anixa Biosciences Transfers Breast Cancer Vaccine IND
    Anixa Biosciences Transfers Breast Cancer Vaccine IND

    15 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/anixa-biosciences-announces-transfer-of-ind-for-breast-cancer-vaccine-from-cleveland-clinic-302640576.html

    PR NEWSWIRE
    15 Dec 2025
    Share Share
    Anixa Bio's Phase 1 Breast Cancer Vaccine Meets Primary Endpoints
    Anixa Bio's Phase 1 Breast Cancer Vaccine Meets Primary Endpoints

    11 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/anixa-biosciences-announces-positive-phase-1-data-for-investigational-breast-cancer-vaccine-primary-endpoints-were-met-and-immune-response-observed-in-74-of-participants-302639634.html

    PR NEWSWIRE
    11 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search